31 – 40 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Intact Free Prostate-Specific Antigen and Free and Total Human Glandular Kallikrein 2. Elimination of Assay Interference by Enzymatic Digestion of Antibodies to F(ab')(2) Fragments.
(
- Contribution to journal › Article
- 2005
-
Mark
Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis.
(
- Contribution to journal › Article
-
Mark
Biochemical markers of bone turnover are influenced by recently sustained fracture.
(
- Contribution to journal › Article
-
Mark
Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy
(
- Contribution to journal › Article
- 2004
-
Mark
Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro
(
- Contribution to journal › Article
-
Mark
Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men
(
- Contribution to journal › Article
-
Mark
Biochemical markers of bone metabolism and prediction of fracture in elderly women.
(
- Contribution to journal › Article
- 2003
-
Mark
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
(
- Contribution to journal › Article
-
Mark
Standardization of Two Immunoassays for Human Glandular Kallikrein 2.
(
- Contribution to journal › Article
- 2002
-
Mark
Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
(
- Contribution to journal › Article